Get started
Author

Kathe L. Stauber

Inhibition of skin tumorigenesis by rosemary and its constituents carnosol and ursolic acid.
1994 · M T Huang, C T Ho, et al. · PubMed · 552
Disposition of the Selective Cholesterol Absorption Inhibitor Ezetimibe in Healthy Male Subjects
2002 · James E. Patrick, Teddy Kosoglou, et al. · Drug Metabolism and Disposition · 164
Safety, Pharmacokinetics, and Efficacy of Olorinab, a Peripherally Acting, Highly Selective, Full Agonist of the Cannabinoid Receptor 2, in a Phase 2a Study of Patients With Chronic Abdominal Pain Associated With Crohn’s Disease
2020 · Bruce R Yacyshyn, Stephen Hanauer, et al. · Crohn s & Colitis 360 · 38
Metabolism and excretion of loratadine in male and female mice, rats and monkeys
2005 · R Ramanathan, N Alvarez, et al. · Xenobiotica · 29
Subchronic to chronic exposure extrapolation: Toxicologic evidence for a reduced uncertainty factor
1995 · Craig S. Nessel, Steven C. Lewis, et al. · Human and Ecological Risk Assessment An International Journal · 28
Radioenzymatic assay of angiotensin-converting enzyme inhibitors in plasma and urine
1985 · Brian N. Swanson, Kathe L. Stauber, et al. · Analytical Biochemistry · 23
A surrogate analyte-based liquid chromatography-tandem mass spectrometry method for the determination of endogenous cyclic nucleotides in rat brain
2017 · Jie Chen, Ali Tabatabaei, et al. · Journal of Pharmaceutical and Biomedical Analysis · 22
PDF
Flow cytometry reveals subpopulations of murine epidermal cells that are refractory to induction of cytochrome P-4501A1 by beta-naphthoflavone.
1995 · K L Stauber, J D Laskin, et al. · Journal of Pharmacology and Experimental Therapeutics · 19
In vitro Drug Metabolism Investigation of 7-Ethoxycoumarin in Human, Monkey, Dog and Rat Hepatocytes by High Resolution LC-MS/MS
2018 · Wan-Yong Feng, Jenny Wen, et al. · Drug Metabolism Letters · 9
PDF
Rapid identification of a novel phosphodiesterase 7B tracer for receptor occupancy studies using LC─MS/MS
2020 · Jie Chen, Guibao Gu, et al. · Neurochemistry International · 6
P139 Olorinab, a Peripherally Restricted, Highly Selective Agonist of the Cannabinoid Receptor Type 2 for the Management of Visceral Pain in Inflammatory Bowel Disease (ibd) – Preclinical and Early Clinical Development
2019 · Beatriz F. Lindstrom, Jon L. Ruckle, et al. · Gastroenterology · 5
Aminocyclohexylsulfonamides: Discovery of metabolically stable α1a/1d-selective adrenergic receptor antagonists for the treatment of benign prostatic hyperplasia/lower urinary tract symptoms (BPH/LUTS)
2007 · George Chiu, Shengjian Li, et al. · Bioorganic & Medicinal Chemistry Letters · 5
Intravenous Infusion of the β3-Adrenergic Receptor Antagonist APD418 Improves Left Ventricular Systolic Function in Dogs With Systolic Heart Failure
2020 · Hani N. Sabbah, Kefei Zhang, et al. · Journal of Cardiac Failure · 3
P139 Olorinab, a Peripherally Restricted, Highly Selective Agonist of the Cannabinoid Receptor Type 2 for the Management of Visceral Pain in Inflammatory Bowel Disease (ibd) – Preclinical and Early Clinical Development
2019 · Beatriz F Lindstrom, Jon L Ruckle, et al. · Inflammatory Bowel Diseases · 2
LC-MS/MS Rapid identification of a novel tracer for a subtype specific phosphodiesterase (PDE) with no known ligand
2019 · Jie Chen, Trevor Scott, et al. · Drug Metabolism and Pharmacokinetics
Rat phenotypic evaluation of several human cytochrome P450 3A4 substrates
2018 · Jenny Wen, Jane Angeles, et al. · Drug Metabolism and Pharmacokinetics
Inhibitory Effect of an Extract of Leaves of Rosmarinus Officinalis L. on Tumor Initiation and Promotion in the Skin of Cd-1 Mice
2005 · M-T. Huang, C-T. Ho, et al. · Elsevier eBooks
Works count: 17
Citation count: 905
H-index: 9
I10-index: 8
Year
Topic
Type